B2B: Kidney Cancer Summary
The 7th Bench-to-Bedside Uro-Oncology: GU Cancers Triad Meeting, organized in conjunction with the 45th Annual Congress of the Société Internationale d’Urologie, was held on 31 October 2025, in Edinburgh, Scotland, and transmitted live on the SIU@U Congress app [...]
Authors
- Simon Tanguay (ORCID: https://orcid.org/0000-0001-6947-304X)
- Amy Clifford
- V. Grünwald
- Karima Oualla
- Christian Kollmannsberger
- Arnaud Méjean
- Axel Bex
Institutions
- BC Cancer Agency (CA)
- Université Paris Cité (FR)
- The Royal Free Hospital (GB)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Européen Georges-Pompidou (FR)
- Hôpital Européen (FR)
- Oncode Institute (NL)
- Essen University Hospital (DE)
- University College London (GB)
- McGill University (CA)
- Sidi Mohamed Ben Abdellah University (MA)
Publication Details
- Journal
- Société Internationale d’Urologie Journal
- Published
- 2026-02-09
- DOI
- https://doi.org/10.3390/siuj7010002
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- AstraZeneca
- Novartis Pharma
- Daiichi Sankyo Europe